StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8522
This month
83
This week
62
This year
3890
Today
11
Yesterday
24
Publishing Date
2023 - 11 - 14
26
2023 - 11 - 13
34
2023 - 11 - 09
47
2023 - 11 - 07
40
2023 - 11 - 06
28
2023 - 11 - 02
37
2023 - 11 - 01
40
2023 - 10 - 31
29
2023 - 10 - 30
25
2023 - 10 - 04
28
2023 - 09 - 07
28
2023 - 09 - 06
41
2023 - 09 - 05
49
2023 - 08 - 14
34
2023 - 08 - 10
27
2023 - 08 - 08
28
2023 - 08 - 07
26
2023 - 08 - 03
39
2023 - 08 - 02
25
2023 - 08 - 01
25
2023 - 06 - 05
25
2023 - 06 - 01
42
2023 - 05 - 31
26
2023 - 05 - 15
31
2023 - 05 - 11
47
2023 - 05 - 10
28
2023 - 05 - 09
32
2023 - 05 - 08
27
2023 - 05 - 04
33
2023 - 05 - 03
25
2023 - 05 - 02
33
2023 - 05 - 01
30
2023 - 04 - 27
30
2023 - 03 - 28
26
2023 - 03 - 15
29
2023 - 03 - 14
27
2023 - 03 - 09
27
2023 - 03 - 07
28
2023 - 03 - 06
29
2023 - 03 - 01
40
2023 - 02 - 28
25
2023 - 02 - 08
25
2023 - 01 - 09
26
2023 - 01 - 04
28
2022 - 11 - 14
31
2022 - 11 - 10
31
2022 - 11 - 03
38
2022 - 10 - 27
26
2022 - 10 - 26
29
2022 - 09 - 06
29
2022 - 03 - 10
28
2022 - 03 - 08
30
2022 - 03 - 03
27
2022 - 03 - 02
26
2022 - 03 - 01
41
2022 - 02 - 22
25
2022 - 02 - 10
24
2022 - 01 - 05
33
2022 - 01 - 04
33
2021 - 12 - 13
33
Sector
Administrative and support and waste management and remediation services
2
Agriculture, forestry, fishing and hunting
1
Commercial services
14
Communications
58
Consumer durables
14
Consumer non-durables
14
Consumer services
38
Distribution services
46
Electronic technology
9
Energy minerals
29
Finance
244
Finance and insurance
10
Health care and social assistance
81
Health services
31
Health technology
6259
Industrial services
2
Information
16
Manufacturing
609
Mining, quarrying, and oil and gas extraction
7
Miscellaneous
10
N/a
396
Non-energy minerals
2
Process industries
15
Producer manufacturing
6
Professional, scientific, and technical services
600
Retail trade
2
Technology services
27
Transportation
1
Transportation and warehousing
4
Utilities
2
Wholesale trade
1
Tags
Acquisition
7901
Agreement
2564
Application
2285
Approval
2292
Business
3501
Cancer
4026
Ceo
2419
Ces
2928
Collaboration
2259
Conference
21681
Corporation
5050
Covid
2710
Deadline
3792
Disease
2544
Distribution
2891
Drug
2624
Earnings
3575
Energy
7241
Europe
2306
Events
4714
Fda
3276
Financial
13170
Financial results
8251
Global
10326
Group
4504
Growth
12167
Health
4734
International
2073
Management
2419
Market
21733
Media
2149
Meeting
3087
N/a
266548
Nasdaq
3513
Offering
6976
Partnership
2612
People
2349
Pharma
2260
Pharmaceuticals
2401
Platform
2170
Positive
2842
Presentation
2961
Program
3581
Report
14256
Research
9950
Results
39074
Sales
2125
Services
2727
Solutions
2412
Spac
2309
Study
2289
System
2460
Technology
6333
Test
2335
Therapeutics
8522
Therapy
2774
Treatment
4972
Trial
6717
Update
4392
Year
4903
Entities
Abbvie inc.
73
Abeona therapeutics inc.
65
Acer therapeutics inc.
54
Adc therapeutics sa
69
Agile therapeutics, inc.
52
Akari therapeutics plc
48
Akebia therapeutics, inc.
59
Akero therapeutics, inc.
53
Aldeyra therapeutics, inc.
54
Aligos therapeutics, inc.
48
Allogene therapeutics, inc.
75
Altamira therapeutics ltd
48
Alterity therapeutics limited
60
Amgen inc.
60
Amicus therapeutics, inc.
48
Aquestive therapeutics, inc.
72
Astrazeneca plc
60
Axsome therapeutics, inc.
66
Bioxcel therapeutics, inc.
50
Cidara therapeutics, inc.
54
Cognition therapeutics inc
69
Crispr therapeutics ag
50
Cytomx therapeutics, inc.
52
Eli lilly and company
117
Fortress biotech, inc.
59
Fulcrum therapeutics, inc.
65
G1 therapeutics, inc.
71
Glaxosmithkline plc
71
Horizon therapeutics public limited company
74
Hoth therapeutics, inc.
61
Inhibikase therapeutics, inc.
57
Intellia therapeutics, inc.
51
Johnson & johnson
160
Kymera therapeutics, inc.
50
Mirati therapeutics, inc.
49
Morgan stanley
127
Nektar therapeutics
50
Novartis ag
98
Omega therapeutics inc
49
Onconova therapeutics, inc.
52
Oncternal therapeutics, inc.
49
Orange
56
Outlook therapeutics, inc.
62
Pliant therapeutics, inc.
60
Plus therapeutics, inc.
78
Poseida therapeutics, inc.
50
Ptc therapeutics, inc.
50
Relief therapeutics holding sa
78
Sanofi
284
Sarepta therapeutics, inc.
62
Seres therapeutics, inc.
55
Spero therapeutics, inc.
63
Springworks therapeutics, inc.
49
Teva pharmaceutical industries ltd
58
Tg therapeutics, inc.
71
Transcode therapeutics inc
53
Travere therapeutics inc.
65
Tscan therapeutics inc
50
Vivos therapeutics inc
51
Voyager therapeutics, inc.
61
Symbols
ABBV
73
ABEO
65
ACER
54
ADCT
69
AGRX
52
AKBA
59
AKRO
53
ALDX
54
ALLO
75
AMGN
60
AQST
72
ATHE
60
AXSM
66
AZN
60
AZNCF
56
BTAI
50
CDTX
54
CGTX
69
CNY
96
CRSP
50
CTMX
52
FBIO
59
FNCTF
56
FULC
65
GLAXF
62
GSK
71
GTHX
71
HOTH
61
HZNP
74
IKT
57
INR
96
JNJ
160
KYMR
50
LLY
117
MCRB
55
MLPY
96
MS
127
MS-PE
86
NKTR
50
NTLA
51
NVS
98
NVSEF
93
ONTX
52
OTLK
62
PLRX
60
PSTV
78
PSTX
50
RLFTF
78
RLFTY
78
RNAZ
53
SNY
284
SNYNF
262
SPRO
63
SRPT
62
TEVJF
58
TGTX
71
TVTX
65
URR
96
VVOS
51
VYGR
61
Exchanges
Amex
58
Lse
13
Nasdaq
8238
Nyse
837
Tsx
7
Crawled Date
2023 - 11 - 14
25
2023 - 11 - 13
35
2023 - 11 - 09
47
2023 - 11 - 07
38
2023 - 11 - 06
27
2023 - 11 - 02
37
2023 - 11 - 01
40
2023 - 10 - 31
29
2023 - 10 - 30
25
2023 - 10 - 04
28
2023 - 09 - 07
28
2023 - 09 - 06
41
2023 - 09 - 05
49
2023 - 08 - 14
34
2023 - 08 - 10
27
2023 - 08 - 08
27
2023 - 08 - 07
26
2023 - 08 - 03
39
2023 - 08 - 02
25
2023 - 08 - 01
25
2023 - 06 - 05
25
2023 - 06 - 01
42
2023 - 05 - 31
26
2023 - 05 - 15
31
2023 - 05 - 11
46
2023 - 05 - 10
29
2023 - 05 - 09
31
2023 - 05 - 08
27
2023 - 05 - 04
33
2023 - 05 - 03
27
2023 - 05 - 02
32
2023 - 05 - 01
61
2023 - 04 - 27
31
2023 - 04 - 19
24
2023 - 03 - 28
26
2023 - 03 - 15
29
2023 - 03 - 14
27
2023 - 03 - 09
27
2023 - 03 - 07
29
2023 - 03 - 06
27
2023 - 03 - 01
40
2023 - 02 - 28
27
2023 - 01 - 09
26
2023 - 01 - 04
28
2022 - 12 - 01
26
2022 - 11 - 14
31
2022 - 11 - 03
36
2022 - 10 - 27
26
2022 - 10 - 26
30
2022 - 09 - 06
28
2022 - 05 - 09
24
2022 - 03 - 10
27
2022 - 03 - 08
28
2022 - 03 - 03
27
2022 - 03 - 02
26
2022 - 03 - 01
40
2022 - 01 - 06
27
2022 - 01 - 05
26
2022 - 01 - 04
31
2021 - 12 - 13
33
Crawled Time
00:00
179
00:11
2
00:20
21
01:00
87
02:00
46
03:00
39
04:00
19
04:20
11
05:00
38
06:00
35
07:00
53
08:00
57
09:00
58
09:08
3
10:00
72
10:16
5
11:00
678
12:00
1264
12:01
19
12:03
24
12:04
2
12:07
4
12:15
44
12:20
425
12:30
160
13:00
999
13:01
9
13:03
22
13:05
6
13:15
27
13:20
332
13:27
2
13:30
205
13:47
3
14:00
620
14:15
14
14:20
174
14:25
3
14:30
115
15:00
262
15:20
57
15:27
4
15:30
60
15:40
7
15:50
8
15:56
4
16:00
144
16:20
32
17:00
151
17:38
5
18:00
133
19:00
153
20:00
459
20:20
16
21:00
420
21:03
9
22:00
404
22:14
8
22:15
4
23:00
254
Source
acertx.com
1
akaritx.com
4
alteritytherapeutics.com
41
atossatherapeutics.com
2
feed.businesswire.com
13
investors.biomarin.com
1
investors.senseibio.com
3
ir.agiletherapeutics.com
16
ir.akerotx.com
25
ir.biolinerx.com
1
ir.catabasis.com
1
ir.cleverleaves.com
1
ir.cyclerion.com
15
ir.hoththerapeutics.com
17
ir.stockpr.com
4
ir.sunesis.com
1
ir.therapeuticsmd.com
3
ir.trevitherapeutics.com
5
ir.vistagen.com
4
ir.voyagertherapeutics.com
28
ir.vtvtherapeutics.com
6
jaguarhealth.gcs-web.com
7
neurosense.investorroom.com
14
nutriband.com
1
seelostherapeutics.com
1
spacfeed.com
46
werewolftx.com
1
www.4dpharmaplc.com
2
www.acertx.com
4
www.allogene.com
20
www.alnylam.com
1
www.appliedtherapeutics.com
1
www.aquestive.com
29
www.arcutis.com
3
www.atossatherapeutics.com
7
www.biospace.com
3758
www.canopygrowth.com
1
www.catalent.com
1
www.cidara.com
2
www.cowen.com
1
www.cuebiopharma.com
1
www.curevac.com
1
www.frequencytx.com
3
www.globenewswire.com
3638
www.halozyme.com
1
www.immunoprecise.com
1
www.invobioscience.com
1
www.isoray.com
1
www.jupiterwellnessinc.com
1
www.prnewswire.com
752
www.respirerx.com
1
www.rubiustx.com
1
www.sutrobio.com
1
www.travere.com
2
www.voyagertherapeutics.com
3
www.vynetherapeutics.com
21
www.zailaboratory.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapeutics
save search
Spyre Therapeutics Announces $180 Million Private Placement
Published:
2023-12-07
(Just crawled : 00:00)
- prnewswire.com
AGLE
|
$12.01
8.79%
8.38%
43K
|
Health Technology
|
Email alert
Add to watchlist
therapeutics
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-12-07
(Crawled : 22:00)
- globenewswire.com
FULC
|
News
|
$4.945
6.8%
6.37%
280K
|
Health Technology
|
Email alert
Add to watchlist
nasdaq
grants
therapeutics
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)
Published:
2023-12-07
(Crawled : 21:00)
- globenewswire.com
ALGS
|
News
|
$0.6475
-5.06%
26.67%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
alg-0001
positive
therapeutics
nash
ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate with Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes
Published:
2023-12-07
(Crawled : 17:00)
- globenewswire.com
ZVSA
|
News
0 d
|
$1.1
-48.6%
-94.55%
4.4M
|
|
0.0%
|
O:
-58.28%
H:
0.0%
C:
0.0%
disease
kidney
publication
therapeutics
diabetes
diabetic
Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published:
2023-12-07
(Crawled : 15:30)
- prnewswire.com
NVS
|
News
1 d
|
$95.93
-1.15%
0.0%
1.2M
|
Health Technology
|
0.0%
|
O:
-1.58%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$155.4
-0.78%
-0.02%
6.4M
|
Health Technology
|
0.0%
|
O:
-1.61%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
0.0%
|
O:
1.97%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.06
0.17%
0.17%
1.9M
|
Health Technology
|
0.0%
|
O:
-1.19%
H:
0.0%
C:
0.0%
REGN
|
News
|
$849.57
1.65%
1.63%
560K
|
Health Technology
|
-0.62%
|
O:
1.63%
H:
0.0%
C:
0.0%
IMNM
|
News
A
|
$7.715
-1.59%
-1.62%
120K
|
Health Technology
|
0.0%
|
O:
-0.26%
H:
0.0%
C:
0.0%
BIIB
|
News
|
$239.14
2.25%
2.2%
1.2M
|
Health Technology
|
0.0%
|
O:
3.35%
H:
0.0%
C:
0.0%
antibody
therapeutics
market
BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS
Published:
2023-12-07
(Crawled : 13:30)
- prnewswire.com
BCLI
|
News
|
$0.2234
-24.86%
-33.08%
6M
|
Health Technology
|
0.0%
|
O:
-15.25%
H:
0.0%
C:
0.0%
nurown
fda
als
cell
meeting
therapeutics
Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
Published:
2023-12-07
(Crawled : 13:00)
- globenewswire.com
CDTX
|
News
|
$0.7331
-3.41%
-3.53%
540K
|
Health Technology
|
0.0%
|
O:
-1.25%
H:
0.0%
C:
0.0%
congress
therapeutics
Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data
Published:
2023-12-07
(Crawled : 12:30)
- globenewswire.com
XLO
|
News
|
$0.8801
-0.01%
10K
|
Professional, Scientific, and T...
|
Email alert
Add to watchlist
xtx101
trial
therapeutics
Kymera Therapeutics Announces First Patient Dosed in Phase 2 Atopic Dermatitis Clinical Trial of KT-474 (SAR444656), a First-in-Class, Investigational IRAK4 Degrader, Generating a $15 Million Payment from Sanofi
Published:
2023-12-07
(Crawled : 12:00)
- globenewswire.com
SNY
|
News
|
$46.06
0.17%
0.17%
1.9M
|
Health Technology
|
0.0%
|
O:
-1.19%
H:
0.0%
C:
0.0%
KYMR
|
News
|
$23.68
7.2%
6.71%
1.1M
|
Health Technology
|
-3.78%
|
O:
4.06%
H:
0.0%
C:
0.0%
kt-474
first
dermatitis
payment
trial
therapeutics
sanofi
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
Published:
2023-12-07
(Crawled : 12:00)
- globenewswire.com
AXSM
|
News
|
$70.22
1.26%
1.24%
630K
|
Health Technology
|
-0.16%
|
O:
-0.36%
H:
0.0%
C:
0.0%
therapeutics
solriamfetol
today
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
Published:
2023-12-07
(Crawled : 12:00)
- globenewswire.com
TCRX
|
News
|
$6.68
-0.89%
-0.9%
96K
|
Professional, Scientific, and T...
|
0.6%
|
O:
0.22%
H:
0.0%
C:
0.0%
global
commercialization
therapeutics
CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel Therapeutics
Published:
2023-12-07
(Crawled : 05:00)
- prnewswire.com
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
0.0%
|
O:
1.97%
H:
0.0%
C:
0.0%
CERE
|
News
|
$41.085
11.25%
10.11%
31M
|
Finance
|
0.0%
|
O:
12.64%
H:
0.0%
C:
0.0%
acquisition
therapeutics
potential
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
Published:
2023-12-06
(Crawled : 22:00)
- prnewswire.com
MS
|
News
0 d
|
$80.35
1.18%
-0.03%
5.3M
|
Finance
|
0.0%
|
O:
-0.56%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
0.0%
|
O:
1.97%
H:
0.0%
C:
0.0%
CERE
|
News
|
$41.085
11.25%
10.11%
31M
|
Finance
|
0.0%
|
O:
12.64%
H:
0.0%
C:
0.0%
abbvie
pipeline
acquire
therapeutics
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program- IND filing expected in mid-2025 -
Published:
2023-12-06
(Crawled : 20:00)
- biospace.com/
VYGR
|
$7.85
3.15%
3.06%
180K
|
Health Technology
|
2.16%
|
O:
2.16%
H:
0.0%
C:
0.0%
SGMO
|
$0.443
-1.14%
-1.15%
850K
|
Health Technology
|
-4.81%
|
O:
-4.81%
H:
0.0%
C:
0.0%
NBIX
M
|
$119.97
0.42%
0.42%
880K
|
Health Technology
|
3.02%
|
O:
3.02%
H:
0.0%
C:
0.0%
candidate
expected
sclerosis
therapeutics
therapy
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published:
2023-12-06
(Crawled : 15:30)
- prnewswire.com
NVS
|
News
1 d
|
$95.93
-1.15%
0.0%
1.2M
|
Health Technology
|
0.17%
|
O:
0.17%
H:
0.0%
C:
0.0%
GSK
|
$36.0
-0.47%
0.06%
2.2M
|
Health Technology
|
0.03%
|
O:
0.03%
H:
0.0%
C:
0.0%
LLY
6 d
|
$588.27
-0.17%
-0.1%
2.1M
|
Health Technology
|
0.99%
|
O:
0.99%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
0.26%
|
O:
0.26%
H:
0.0%
C:
0.0%
DNLI
|
$18.72
-2.19%
-2.24%
1.1M
|
Health Technology
|
-0.22%
|
O:
-0.22%
H:
0.0%
C:
0.0%
BIIB
|
News
|
$239.14
2.25%
2.2%
1.2M
|
Health Technology
|
0.46%
|
O:
0.46%
H:
0.0%
C:
0.0%
disease
parkinson's
revenue
research
therapeutics
market
CARGO Therapeutics Announces Scientific Advisory Board
Published:
2023-12-06
(Crawled : 15:30)
- biospace.com/
CRGX
|
$16.0
7.67%
7.13%
92K
|
|
2.71%
|
O:
2.71%
H:
0.0%
C:
0.0%
therapeutics
Coya Therapeutics Announces $26.5 Million Private Placement
Published:
2023-12-06
(Crawled : 14:30)
- biospace.com/
COYA
|
$7.27
0.41%
0.41%
64K
|
|
-6.04%
|
O:
-6.04%
H:
0.0%
C:
0.0%
therapeutics
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
Published:
2023-12-06
(Crawled : 14:30)
- invobioscience.com
INVO
|
$1.53
-6.71%
-7.19%
240K
|
Health Technology
|
3.77%
|
O:
3.77%
H:
0.0%
C:
0.0%
partnership
natural
cell
research
therapeutics
therapy
Cidara Therapeutics Announces Completion of Enrollment in Phase 3 Restore Trial of Rezafungin in China
Published:
2023-12-06
(Crawled : 13:00)
- globenewswire.com
CDTX
|
News
|
$0.7331
-3.41%
-3.53%
540K
|
Health Technology
|
-4.19%
|
O:
-4.19%
H:
0.0%
C:
0.0%
rezafungin
trial
therapeutics
china
Outlook Therapeutics® Announces Strategic Organizational Realignment
Published:
2023-12-06
(Crawled : 13:00)
- globenewswire.com
OTLK
|
News
|
$0.4443
-0.16%
-0.16%
870K
|
Health Technology
|
-0.9%
|
O:
-0.9%
H:
0.0%
C:
0.0%
therapeutics
← Previous
1
2
3
4
5
6
7
8
9
…
426
427
Next →
Gainers vs Losers
69%
31%
Top 10 Gainers
SLDB
|
News
M
|
$5.89
72.22%
41.94%
12M
|
Health Technology
SVFD
|
News
|
$3.09
43.72%
30.42%
64M
|
FTEL
|
$2.04
43.66%
30.39%
110K
|
HPCO
4
|
$0.4824
41.92%
29.54%
28M
|
ALGS
|
News
|
$0.6475
-5.06%
26.67%
2.1M
|
Health Technology
GTHX
|
$3.16
30.58%
23.42%
10M
|
Health Technology
KEQU
|
$22.5
27.62%
21.64%
24K
|
Producer Manufacturing
GSIT
|
$3.09
27.16%
21.36%
2.2M
|
Electronic Technology
SSKN
P
|
$0.628
25.6%
20.38%
210K
|
Health Technology
GLUE
|
$3.66
22.82%
18.58%
510K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.